Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine plus magnesium sulfate versus ropivacaine plus magnesium sulfate for postoperative pain after lumbar laminectomy
IRCT20160430027677N18Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine + magnesium sulfate with Bupivacaine + magnesium sulfate (2 arms). Primary endpoint: Postoperative pain. Started Jan 2019; status: completed.
02
Drugs
bupivacaineropivacainemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160430027677N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160430027677N18.